This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Innovation
Curecall start-up
Curecall: a smart SMS tool for better chronic patient monitoring
Unither Pharmaceuticals wants to strengthen its relationship with pharmaceutical companies by offering them an e-health solution. The collaboration with Pathfinder (a corporate venture builder) has led to the creation of the start-up Curecall, which is developing an intelligent SMS tool to improve monitoring of chronic patients. For Unither, this project will enable it to provide more services to its customers (compliance, real-life data, patient pathways, clinical trials, etc.).
Patient, customer and ophthalmologic benefits
- Available for each ocular pathology: glaucoma, age-related macular degeneration (AMD), cataract, diabetic maculopathy, diabetic retinopathy, dry eye, ocular allergies and ocular tumours
- Simplifies patient management
- Saves time for healthcare professionals by automating their follow-up via SMS
- Over 20,000 patients monitored
- Real time data
Technology
Unlike applications, SMS is less sensitive to categorical differences such as age
- 95% open rate and no patient set-up required
- Higher performance and efficiency than any other communication medium
Who is the solution for?
- Ophthalmological centres that wish to follow their patients remotely
- Hospitals & clinics for eye surgery preparation
- E-health industries
- Pharmaceutical laboratories and CROs conducting clinical trials
Curecall
Curecall was launched in January 2020 and has raised €2.3 million in 2 investment rounds. Its mission? To equip healthcare professionals with intelligent and efficient technologies to improve the management of chronic patients through secure conversational medical solutions.